Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-153415
Filing Date
2025-07-01
Accepted
2025-07-01 06:51:50
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d89513ds3.htm S-3 460090
2 EX-1.2 d89513dex12.htm EX-1.2 237868
3 EX-4.5 d89513dex45.htm EX-4.5 270134
4 EX-4.6 d89513dex46.htm EX-4.6 262014
5 EX-5.1 d89513dex51.htm EX-5.1 14347
6 EX-5.2 d89513dex52.htm EX-5.2 7786
7 EX-23.1 d89513dex231.htm EX-23.1 1852
8 EX-FILING FEES d89513dexfilingfees.htm EX-FILING FEES 55320
9 GRAPHIC g89513g29d85.jpg GRAPHIC 42334
  Complete submission text file 0001193125-25-153415.txt   1368766
Mailing Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110
Business Address 99 HIGH STREET SUITE 2100 BOSTON MA 02110 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-288444 | Film No.: 251094137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)